AbbVie finally gets Shire, its low tax base and enough new drugs to protect its future

Eric Palmer With a bid reaching nearly $ 55 billion and some goodies for the top execs, AbbVie was finally able to get Ireland-based Shire to surrender its independence, a portfolio ...

FedEx indicted for delivering drugs to addicts from illegal web pharmacies

Eric Palmer FedEx has received a special delivery from the U.S. Department of Justice (DoJ), a 15-count indictment accusing it of being the delivery vehicle of choice for a certain ...

EMA approves 39 drugs in H1, down from 44 last year

Eric Palmer The European Medicines Agency approved 39 new drugs in the first half of the year, PharmaTimes reports. FiercePharma News

PBMs join chorus of support for easy names on biosimilar drugs

Tracy Staton The FDA is getting an earful from another group intent on saving money on biotech drugs. A coalition of pharmacies, health insurers, unions and pension plans asked the ...

Study: Med students cozy with pharma reps more likely to dole out branded drugs

Emily Wasserman Doctors aren't the only ones to fall prey to free lunches and fuzzy promotional talks. Medical students who spend more time with& pharma reps are more likely ...

Naurex picks up $25M to get its depression drugs through PhII

Damian Garde Evanston, IL's Naurex nailed down another $ 25 million in venture funding to accelerate its two-pronged depression program, posting positive mid-stage results for ...

Vertex, once king of hep C category, bows out as new drugs eclipse Incivek

Eric Palmer Biotech Vertex has pulled the plug on work in the hepatitis C arena, an area it was expected to dominate with its Incivek until Gilead Sciences redefined the category with ...

Pfizer expansion allows it to make drugs for trials at Cork, Ireland, facility

Eric Palmer Pfizer has opened an expanded product technology laboratory at its Ringaskiddy, County Cork, facility. The company has invested about $ 30 million in the lab, Business ...

National Cancer Institute investigating trial outliers to resurrect ‘failed’ drugs

Emily Mullin After sifting through 10 years' worth of clinical trial data, NCI's Cancer Diagnosis Program says the program has identified about 100 "exceptional responders": ...

Critics knock JAMA study linking testosterone drugs to cardio risks

Carly Helfand A study the FDA has cited as a reason to investigate the cardiovascular safety of testosterone drugs has come under heavy fire from critics. Physicians and researchers ...

Sage snags $38M from A-list VCs to bankroll its seizure drugs

Damian Garde Cambridge, MA's Sage Therapeutics has hauled in a $ 38 million Series C, convincing a who's-who of biotech investors to pitch in as it pushes forward with a portfolio ...

Allergan rides high on patent backing for key drugs Lumigan and Restasis

Carly Helfand Patent-cliff worries have been weighing on Allergan as of late, but a Texas judge has allayed some of those concerns–at least for now. That judge upheld ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS